The Severe Disruptive Disorders Program offers a range of superspecialized services for children aged 6 to 12 years with behaviour problems with or without an attention deficit disorder / hyperactivity disorder (ADHD).

Classes are held every Tuesdays at 7 PM, from October 23 to November 27, 2007. They were overseen by Hani Iskandar, MD, Clinical Chief at Psychiatric Intensive Care Unit and Coordinator in Undergraduate Medical Education at Douglas I

By exploring the history of psychiatry, by being informed about the current challenges and by studying future prospects in psychiatry and neuroscience, participants have learnt to distinguish between the myths and realities surrounding mental illne

Mental Illness: The Facts and the Fiction The theme of the 2009 Session of Mini-Psych is Mental Illness: The Facts and the Fiction. Each of the 6 classes given by an expert from the Douglas Institute is exploring the

By bringing together experts in the fields of psychology and psychiatry with members from the community, the Mini-Psych School will provide easily accessible information about the brain and mental disorders, why they appear, what happens when they appear and ways to treat them.

The Douglas Institute offers its residents the opportunity to acquire a developmental perspective of the individual, from infancy through childhood, adolescence, adulthood and into old age.

The primary focus of the undergraduate program is to teach and help the students apply core knowledge, skills and attitudes required of a medical professional. The goal of the program is to equip the student to meet the most stringent standards of

The Douglas shares its knowledge with students, staff members, researchers, mental health professionals, workers, and the general public.

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.